Literature DB >> 637582

Surgical management of massive hemoptysis. A ten-year experience.

A A Garzon, A Gourin.   

Abstract

Pulmonary bleeding was defined as massive when the collected blood was 600 ml or more in 24 hours. Hemoptysis of this magnitude carries more than 50% mortality when managed without surgical intervention, For this reason all patients admitted, bleeding massively, in the past ten years were considered candidates for surgical therapy. Localization of the bleeding was done by bronchoscopy. Pulmonary reserve was evaluated by clinical and radiological observation and, when feasible, by spirometry. Of the 75 patients seen with massive hemoptysis, 68 were operated. Seven patients were excluded for various reasons. Five of these patients died during the acute bleeding episode. Sixt-five resections were performed with 11 deaths (17%) and three cavernostomies with one death. Of 51 lobectomies, seven expired (14%). One segmentectomy survived. Other than the magnitude of the surgical resection, the mortality was related to the amount of bleeding in the 24 hours preceding the surgical procedure. Severe bleeding at the time of resection requiring one-lung ventilation also significantly influenced the mortality (33% against 7%). This experience shows that pulmonary resection is the treatment of choice in patients with massive hemoptysis.

Entities:  

Mesh:

Year:  1978        PMID: 637582      PMCID: PMC1396417          DOI: 10.1097/00000658-197803000-00010

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  5 in total

1.  Control of hemorrhage in emergency pulmonary resection for massive hemoptysis.

Authors:  A Gourin; A A Garzon
Journal:  Chest       Date:  1975-07       Impact factor: 9.410

2.  Operative treatment of massive hemoptysis.

Authors:  A Gourin; A A Garzon
Journal:  Ann Thorac Surg       Date:  1974-07       Impact factor: 4.330

3.  Surgical advantages of selective unilateral ventilation.

Authors:  R E Wood; D Campbell; M A Razzuk; D L Paulson; H C Urschel
Journal:  Ann Thorac Surg       Date:  1972-08       Impact factor: 4.330

4.  Massive hemoptysis.

Authors:  J A Crocco; J J Rooney; D S Fankushen; R J DiBenedetto; H A Lyons
Journal:  Arch Intern Med       Date:  1968-06

5.  Pulmonary resection for massive hemoptysis.

Authors:  A A Garzon; M Cerruti; A Gourin; K E Karlson
Journal:  Surgery       Date:  1970-04       Impact factor: 3.982

  5 in total
  19 in total

1.  Management of Massive Hemoptysis: Analyses of 58 Patients.

Authors:  Alkın Yazıcıoğlu; Erdal Yekeler; Ülkü Yazıcı; Ertan Aydın; İrfan Taştepe; Nurettin Karaoğlanoğlu
Journal:  Turk Thorac J       Date:  2016-10-01

Review 2.  A systematic approach to the management of massive hemoptysis.

Authors:  Christopher Radchenko; Abdul Hamid Alraiyes; Samira Shojaee
Journal:  J Thorac Dis       Date:  2017-09       Impact factor: 2.895

3.  Treatment of massive hemoptysis with intravenous pitressin.

Authors:  G Magee; M H Williams
Journal:  Lung       Date:  1982       Impact factor: 2.584

4.  Outcome and complications of bronchial artery embolisation for life-threatening haemoptysis.

Authors:  M M Slattery; A N Keeling; M J Lee
Journal:  Ir J Med Sci       Date:  2008-10-25       Impact factor: 1.568

Review 5.  Massive hemoptysis.

Authors:  T W Noseworthy; B J Anderson
Journal:  CMAJ       Date:  1986-11-15       Impact factor: 8.262

6.  Lessons from patients with hemoptysis attending a chest clinic in India.

Authors:  Rajendra Prasad; Rajiv Garg; Sanjay Singhal; Piyush Srivastava
Journal:  Ann Thorac Med       Date:  2009-01       Impact factor: 2.219

7.  Recurrent major haemoptysis: progression to pneumonectomy.

Authors:  W A Baumgartner; J B Mark
Journal:  Thorax       Date:  1980-12       Impact factor: 9.139

Review 8.  Antifibrinolytic therapy to reduce haemoptysis from any cause.

Authors:  Gabriela Prutsky; Juan Pablo Domecq; Carlos A Salazar; Roberto Accinelli
Journal:  Cochrane Database Syst Rev       Date:  2016-11-02

9.  Characteristics and Treatment Outcomes of Patients with Tuberculosis Receiving Adjunctive Surgery in Uzbekistan.

Authors:  Anvar Riskiyev; Ana Ciobanu; Arax Hovhannesyan; Kristina Akopyan; Jamshid Gadoev; Nargiza Parpieva
Journal:  Int J Environ Res Public Health       Date:  2021-06-17       Impact factor: 3.390

10.  Risk factors influencing rebleeding after bronchial artery embolization on the management of hemoptysis associated with pulmonary tuberculosis.

Authors:  Hun-Gyu Hwang; Ho-Sung Lee; Jae-Sung Choi; Ki-Hyun Seo; Yong-Hoon Kim; Ju-Ock Na
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.